Ectopic Pregnancy Market Size, Share, Industry Analysis, Segments And Forecast To 2033

"The new report published by The Business Research Company, titled ""Ectopic Pregnancy Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the ectopic pregnancy market size has grown strongly in recent years. It will grow from $7.62 billion in 2023 to $8.09 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The ectopic pregnancy market size is expected to see strong growth in the next few years. It will grow to $10.35 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16042&type=smp

Increased Utilization Of Contraceptive Devices Driving Ectopic Pregnancy Market Growth
The increase in the use of contraceptive devices is expected to propel the growth of the ectopic pregnancy market going forward. Contraceptive devices are tools used to prevent pregnancy by inhibiting the fertilization of an egg or the implantation of a fertilized egg. The use of contraceptive devices is increasing due to a growing emphasis on family planning, population control, and the desire to prevent unintended pregnancies. The increasing use of contraceptive devices, particularly intrauterine devices (IUDs), can elevate the risk of ectopic pregnancy if pregnancy occurs, as these devices can alter the normal movement of the egg through the fallopian tubes, leading to implantation outside the uterus. For instance, in February 2024, according to the Faculty of Sexual and Reproductive Healthcare (FSRH), a UK-based organization for family planning and sexual health, from 2022 to 2023, the utilization of long-acting reversible contraceptives (LARC) rose to 44.1 per 1,000 people, up from 41.8 per 1,000 in the preceding year, 2021 to 2022. Therefore, the increase in the use of contraceptive devices is driving the growth of the ectopic pregnancy market.

AI-Powered Ultrasound Systems Revolutionize Ectopic Pregnancy Diagnosis
Major companies operating in the ectopic pregnancy market are developing artificial intelligence (AI)-powered ultrasound systems to enhance diagnostic accuracy and improve patient outcomes. AI-powered ultrasound systems use machine learning algorithms to analyze ultrasound images, enhancing the accuracy and speed of ectopic pregnancy diagnosis. For instance, in September 2021, Samsung Medison, a South Korea-based medical device company, introduced the V8, an AI-enabled ultrasound system. The V8 features BiometryAssist, which automates fetal biometry measurements, and LaborAssist, which helps clinicians determine the progression of labor by automatically identifying the fetal position. These advancements significantly improve the efficiency and precision of ectopic pregnancy detection, potentially reducing the risk of complications.

The ectopic pregnancy market covered in this report is segmented -

1) By Type: Tubal Ectopic Pregnancy, Non-Tubal Ectopic Pregnancy, Heterotopic Ectopic Pregnancy, Other Types
2) By Treatment: Folic Acid Analogue, Corticosteroid, Other Treatments
3) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospital Pharmacies, Other Distribution Channels
4) By End-User: Hospitals, Clinics, Fertility Centers, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16042&type=discount

Major companies operating in the ectopic pregnancy market are Pfizer Inc., F. Hoffmann-La Roche Ltd, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, Fresenius Kabi USA, Eli Lilly and Company, Amgen Inc., Merck KGaA, Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Aurobindo Pharma USA, H. Lundbeck A/S, Dr. Reddy's Laboratories, Hikma Pharmaceuticals Plc, Lupin Pharmaceuticals Inc., Zydus Pharmaceuticals, Stason Pharmaceuticals, Actiza Pharmaceutical Private Limited, Zhejiang Davi Pharmaceutical Co., Ltd.

Contents of the report:
1. Executive Summary
2. Ectopic Pregnancy Market Report Structure
3. Ectopic Pregnancy Market Trends And Strategies
4. Ectopic Pregnancy Market - Macro Economic Scenario
5. Ectopic Pregnancy Market Size And Growth
…..
27. Ectopic Pregnancy Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/ectopic-pregnancy-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.